Newsvine
  • Welcome
  • Help
  • Report Bug
  • Conversation Tracker
  • Your Column
  • Replies
  • Friends
Type Comments Since You Last CheckedArticle Source Last Checked Stop Tracking All Clear Tracking All
Advertise | AdChoices
Log In | Register
Close the Login Panel
Existing users log in below. New users please register for a free account.

New Users:

Existing Users:

E-Mail:
Password:
Forgot Password?
Please enter the e-mail address or domain name you registered with:
E-Mail/Domain:
Back to Login
Log Out
  • Top News
  • Local News
  • World
  • U.S.
  • Sports
  • Politics
  • Tech
  • Entertainment
  • Science
  • Business
  • Health
  • Odd News
  • More
    • Arts
    • Education
    • Environment
    • Fashion
    • History
    • Home & Garden
    • Not News
    • Religion
    • Travel
What is Newsvine?

Updated continuously by citizens like you, Newsvine is an instant reflection of what the world is talking about at any given moment.

Get a Free Account
Help
Fun Stuff
  • Your Clippings
  • Leaderboard
  • E-Mail Alerts
  • Top of the Vine
  • Newsvine Live
  • Newsvine Archives
  • The Greenhouse
  • Recommended Articles
  • Wall of Vineness
Put a Seed Newsvine link on your own site

Cystic Fibrosis: More patients live into adulthood

Mon Jun 21, 2010 4:05 PM EDT
health, us, med, healthbeat, cystic-fibrosis, laura-mentch
Lauran Neergaard, AP Medical Writer
< PreviousNext >
showing 1 of 2 photos
<p>This undated handout photo provided by Laura Mentch, shows Laura Mentch, 57, of Bozeman, Mont., with her daily treatments for cystic fibrosis, which include inhaled medications and a chest-vibrating vest to clear airway clogs. More CF patients are surviving to middle age and beyond, and Mentch is part of a special subset — people not even diagnosed until later in life. (AP Photo/Michael Brody)</p>

This undated handout photo provided by Laura Mentch, shows Laura Mentch, 57, of Bozeman, Mont., with her daily treatments for cystic fibrosis, which include inhaled medications and a chest-vibrating vest to clear airway clogs. More CF patients are surviving to middle age and beyond, and Mentch is part of a special subset — people not even diagnosed until later in life. (AP Photo/Michael Brody)

Advertise | AdChoices

WASHINGTON — Doctors always said allergies and asthma were behind Laura Mentch's repeated lung and sinus infections. Only when she turned 50 did she discover the real culprit — a disease notorious for destroying children's lungs.

Mentch is part of the gradual graying of cystic fibrosis: More and more patients are surviving into adulthood, some even to middle age and beyond.

Now, researchers are taking a close look at the first group to make it past age 40 with this incurable genetic disease, as a much-needed guide for patients and doctors on what to expect.

And they're finding CF is even more complicated than thought. Consider Mentch: The Bozeman, Mont., woman is part of a small but growing subset of patients not diagnosed until adulthood — patients long assumed merely to have a mild version of the disease that, in its classic form, can quickly attack lungs.

Not so, contends Dr. Jerry Nick of National Jewish Health in Denver, home of one of the largest adult CF treatment centers. He studied how more than 3,000 long-term survivors fared, both at his center and using data from patients included in the Cystic Fibrosis Foundation's national registry over 15 years. He found that once their disease revs up, those diagnosed as adults can deteriorate as quickly as those diagnosed younger.

"It's not really mild CF, it's delayed CF," says Nick, whose study was published last month in the American Journal of Respiratory and Critical Care Medicine.

If so, his findings may have ramifications for babies as well. How? In recent years, every state has begun screening newborns for cystic fibrosis, so that patients can start life-extending treatment before that first infection ever hits.

But doctors are having trouble determining if a fraction of those babies really will develop CF or not, because they harbor less common genetic mutations than the classic type linked to early, severe disease.

"We're struggling with this," says Dr. Bruce Marshall of the Cystic Fibrosis Foundation, which issued guidelines in December recommending such children be closely monitored for signs of disease as they grow. "At this point, we really don't know exactly what to do with these folks."

Those less common mutations are the same ones Nick says he's seeing in people, like Mentch, whose CF wasn't diagnosed until adulthood.

"This says you shouldn't dismiss it" in the babies with those ambiguous test results, Nick cautions. "This is not the classic CF of 30 years ago."

About 30,000 Americans, and 70,000 people worldwide, are living with cystic fibrosis, caused by inheriting a flawed CF gene from each parent. The disease causes a sticky mucus to build up in the lungs, clogging them and leading to life-threatening infections. It also clogs the pancreas so the body can't properly digest food.

Only a few decades ago, children with CF seldom survived elementary school. Today, thanks to earlier diagnosis and improved treatments, 47 percent reach 18 or older. Most of the 400 deaths a year are among teenagers and young adults, according to the CF Foundation's registry.

So far, just over 5 percent of patients in the registry have made it beyond age 40 — although Nick's study suggests some who seek care outside that network aren't counted — and babies diagnosed today are expected to live into their 50s.

Beyond the adult-diagnosed phenomenon, Nick found patients who'd battled CF since childhood and bear the highest-risk gene type survived, too, showing there's still lots to learn about factors that play a role. While the adult-diagnosed of course lived the longest, anyone who made it to 40 had a good chance of surviving another decade.

Nick's main message: Proper care during adulthood fights the lung damage. Yet regardless of when they were diagnosed, Nick found, fewer than half of long-term survivors are treated at the nation's specially designated CF centers once they pass 40 — while those who do fare better.

Mentch's lung function greatly improved after the right diagnosis got her the right treatment, ending regular bouts of bronchitis she'd experienced since her teens.

"It's not OK to have bronchitis twice a year and think it's normal, but that's ... how I walked through life," says Mentch, now 57, who was diagnosed only when a doctor tested her sputum and found a type of Pseudomonas bacterium trapped in her lungs, a red flag for CF.

Now Mentch travels to the Denver CF clinic four times a year to stay on top of her care, which includes inhaled medications and a chest-vibrating vest to clear airway clogs. As the disease progresses, she says, "I have a huge responsibility to take care of myself."

___

EDITOR'S NOTE — Lauran Neergaard covers health and medical issues for The Associated Press in Washington.

___

Online:

Cystic Fibrosis Foundation: http://www.cff.org

© 2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
  • Enjoy this article? Help vote it up the 'Vine.

Back To Top | Front Page

Published to:

  • Lauran Neergaard's Column, All of Newsvine
  • Groups: none
  • Regions: Washington DC
  • Public Discussion (1)
dghdhgDeleted
RiHo08

At first the diagnosis of Cystic Fibrosis was simple, that is 50 years ago. Today it is complicated. With the discovery of the "CF gene" in 1989, the future of CF was to find a way to correct the genetic defect, inserting a corrected copy into the person's genome, replacing the defective gene. What has ensued, is the discovery of a remarkable variation in the gene, its gene expression, the interchange between gene and environment, and therapies applied to the individual patients. Patients are living longer, that's good. What has not been so well studied, and this may be the key to understanding Cystic Fibrosis, why does a lethal genetic defect continue to survive in the population. Under simple Mendalian Genetics, lethal genes quickly die out because there are fewer and fewer survivors. Not so for Cystic Fibrosis. The current CF births/1000 live birth experience with Cystic Fibrosis is similar to that as in the past. Why? There has been speculation that those who carry one copy of the CF gene benefit in some way from carrying one copy. Obviously carrying both copies of the genetic defect results in Cystic Fibrosis related symptoms and an early death. A lot of research has been invested in mitigating the results of inheriting two copies of the CF gene. Possibly, to better understand CF, more research effort needs to go into the potential benefits of carrying one copy of the CF gene. Genetics is interesting as the Human Genome Project illustrates. Understanding the positive aspects of carrying one copy of the CF gene may be worth pursuing more than in an observational manner.

    Reply#2 - Wed Jun 23, 2010 9:25 PM EDT
    Leave a Comment:
    You're in Easy Mode. If you prefer, you can use XHTML Mode instead.
    You're in XHTML Mode. If you prefer, you can use Easy Mode instead.
    (XHTML tags allowed - a,b,blockquote,br,code,dd,dl,dt,del,em,h2,h3,h4,i,ins,li,ol,p,pre,q,strong,ul)
    Newsvine Privacy Statement
    As a new user, you may notice a few temporary content restrictions. Click here for more info.
    FUN STUFF:
    • Leaderboard |
    • E-Mail Alerts |
    • Top of the Vine |
    • Newsvine Live |
    • Newsvine Archives |
    • The Greenhouse
    COMPANY STUFF:
    • Code of Honor |
    • Company Info |
    • Contact Us |
    • Jobs |
    • User Agreement |
    • Privacy Policy |
    • About our ads
    LEGAL STUFF:
    • © 2005-2012 Newsvine, Inc. |
    • Newsvine® is a registered trademark of Newsvine, Inc. |
    • Newsvine is a property of msnbc.com